Estrella Immunopharma Inc. (ESLA)
NASDAQ
Closed
Aug 25, 2026
Day's Range
0.750352 wk Range
0.6780Profile - ESLA - Estrella Immunopharma Inc.
Profile
Mic Code
XNCM
Sector
Healthcare
Industry
Biotechnology
Employees
0
Estrella Immunopharma Inc. is a biotechnology company dedicated to the research and development of innovative therapies. Primarily focusing on creating advanced treatment options for cancer and other serious diseases, the company harnesses cutting-edge technologies to address unmet medical needs. Estrella Immunopharma operates within the highly impactful biopharmaceutical sector, where its contributions can have significant implications for healthcare treatments globally. With a commitment to scientific excellence, the company engages in the discovery of novel drug candidates, advancing them through rigorous clinical trials. Estrella Immunopharma is pivotal in translating scientific innovations into viable medical solutions, contributing to the growing field of personalized medicine. Its role in the market is significant, given the increasing demand for targeted therapies and advancements in medical technology. As a part of the pharmaceutical industry, it not only influences healthcare advancements but also impacts clinical practices, offering potential pathways to improve patient outcomes through novel and effective treatment modalities.
Profile Details
Type
Common Stock
Ceo
Dr. Cheng Liu Ph.D.
Address
5858 Horton Street
City
EmeryVille
State
CA
Zip
94608
Country
United States
Phone
510 318 9098
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
